FDA — authorised 26 July 2012
- Application: NDA202020
- Marketing authorisation holder: HORIZON
- Local brand name: RAYOS
- Indication: TABLET, DELAYED RELEASE — ORAL
- Status: approved
FDA authorised Prednisone Oral Product on 26 July 2012
Yes. FDA authorised it on 26 July 2012.
HORIZON holds the US marketing authorisation.